Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...
Oculis’ neuroprotective candidate privosegtor receives US FDA breakthrough therapy designation to treat optic neuritis: Zug, Switzerland Thursday, January 8, 2026, 17:00 Hrs [IS ...
Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing ...
Multiple milestones anticipated from late-stage portfolio including topline results from DIAMOND Phase 3 trials with OCS-01 ...
Lokelma (sodium zirconium cyclosilicate) is a prescription drug used to treat high blood potassium levels. Examples of side effects of Lokelma include fluid swelling in areas of the body and low blood ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of KANDLELIT-007, a ...
Diarrhea is a common side effect of Ozempic due to the medication’s effect on the digestive system, which slows nutrient absorption. Dietary adjustments, such as eating smaller meals and avoiding ...
Everyday Health on MSN
These are the 10 best collagen supplements dietitians love in 2026
These are the best collagen supplements for healthier skin and stronger joints, according to dietitians. Top picks include ...
Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback